No Data
No Data
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Celcuity (CELC) and Icon (ICLR)
Celcuity Is Maintained at Buy by Needham
Celcuity Is Maintained at Buy by Needham
Express News | Celcuity Inc : Needham Cuts Target Price to $23.00 From $24.00
Celcuity Shares Rise 8.2% After $60 Million Offering Prices
By Chris Wack Celcuity shares were up 8.2% to $16.06 after the company priced an underwritten offering of 3.9 million shares at an offering price of $15.50 a share. All of the securities are to be s
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
Health care stocks were mixed pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) gaining 0.2%. Sarepta Therapeutics (SRPT) shares a
Celcuity Plans Phase 3 Trial of Potential Breast Cancer Therapy, Receives Additional Term Loan
Celcuity (CELC) said Thursday it plans to launch a phase 3 clinical trial to evaluate gedatolisib in combination with other drugs as a first-line treatment for patients with HR+/HER2- advanced breast
70846396 : Do you offer a trading platform for e minis&p500 futures?
Slee49 :
Elyx : Cool
101698910 : crypto is up again. believe in Cathie wood
Moomoo Breakfast USOP 70846396: Thanks for the comment. Currently, only SG user could trade future on moomoo.
View more comments...